PRPHMICRO

ProPhase Labs, Inc.

HealthcareDrug Manufacturers - Specialty & Generic
$0.14
$0.00(-5.72%)
52W$0.07
$1.84
Updated May 7, 12:00 AM
RSI60
RS Rating5/99
Beta2.28
Volatility171%
F-Score1/9
Mkt Cap$6M
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

ProPhase Labs, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 5), showing significant lag compared to the market leaders. Earnings growth of 54% provides fundamental context to the price action. However, price is extended 23% above the 50-day line, increasing the risk of a mean reversion.

Relative Strength
5
out of 99
Lagging
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
2.28
vs S&P 500
HIGH BETA
52W Position
4%
from 52W low
Near Low
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$0.11
50 SMA > 100 SMA$0.24
100 SMA > 150 SMA$1.28
150 SMA > 200 SMA$1.91

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$0.12+18.14%ABOVE
50 SMA$0.11+22.91%ABOVE
100 SMA$0.24-42.41%BELOW
150 SMA$1.28-89.09%BELOW
200 SMA$1.91-92.68%BELOW

Price Performance

1D-5.7%
1W+22.8%
1M+69.9%
3M-6.7%
6M-49.9%
YTD-61.1%
1Y-48.2%
3Y-67.8%
52-Week Trading Range4% from low
$0.14
52W Low$0.07
52W High$1.84

Technical Indicators

RSI (14)NEUTRAL
59.9
305070
VCP ScoreCOOL
5/10
Base depth: 83.6%

Risk Profile

Beta
2.28
52W Vol
171%
ATR
$0.03
Max DD (1Y)
-93%

Volume Analysis

Today
2.6K
50D Avg
106.0K
Vol Ratio
0.02x
Liquidity
ILLIQUID

Earnings Momentum

Q4'24-229%
$-1.58
Q1'25+160%
$0.21
Q2'25+67%
$-0.11
Q3'25+54%
$-0.16
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:-11.15%
5 Years:-7.27%
3 Years:-55.92%
TTM:-91.55%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:-8.61%

Stock Price CAGR

10 Years:-25.22%
5 Years:-45.07%
3 Years:-67.77%
1 Year:-48.24%

Return on Equity

10Y Avg:-7.3%
5Y Avg:-37.8%
3Y Avg:-62.5%
Last Year:-607.8%

Key Metrics

Market Cap$6M
Gross Margin-2.2%
Net Margin-7.9%
Piotroski F-Score1/9

Frequently Asked Questions

Is PRPH in an uptrend right now?

PRPH has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is PRPH overbought or oversold?

PRPH's RSI (14) is 60. The stock is in neutral territory, neither overbought nor oversold.

Is PRPH outperforming the market?

PRPH has a Relative Strength (RS) Rating of 5 out of 99. PRPH is currently lagging the broader market.

Where is PRPH in its 52-week range?

PRPH is trading at $0.14, which is 8% of its 52-week high ($1.84) and 4% above its 52-week low ($0.07).

How volatile is PRPH?

PRPH has a Beta of 2.28 and 52-week volatility of 171%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.